Fig. 2From: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysisKaplan–Meier survival curves of the 448 patients in the propensity score-matched cohort. a Overall survival; b distant metastasis-free survival; c Local recurrence-free survival; d Nodal recurrence-free survivalBack to article page